Tinghua CAO
About Tinghua CAO
Tinghua Cao is a Principal Scientist at Bristol Myers Squibb with over 20 years of experience in immunology and pharmaceutical research.
Title and Current Position
Tinghua CAO currently holds the position of Principal Scientist at Bristol Myers Squibb, located in California, United States. He has been with the company since January 2021, where he continues to contribute to the field of immunology and pharmaceutical research.
Previous Roles and Work Experience
Before joining Bristol Myers Squibb, Tinghua CAO served as a Senior Scientist at Celgene in San Diego, CA, from 2017 to 2021. Prior to that, he was a Senior Research Scientist at Janssen R&D (Centocor R&D), part of Johnson & Johnson, based in Spring House, PA, from 2009 to 2017. From 2005 to 2009, he worked at Johnson & Johnson/Therakos as a Senior Scientist/Scientist. Earlier in his career, from 2002 to 2005, he was a Postdoctoral Associate at Baylor Institute for Immunology Research.
Education and Academic Background
Tinghua CAO earned his Ph.D. in Immunology from Ghent University, where he studied from 1996 to 2001. He also spent six years at the University of Ghent as a Research Fellow and Ph.D. Candidate in Immunology. Prior to that, he pursued studies at Hubei Medical University. His extensive academic background laid a strong foundation for his career in immunology and pharmaceutical research.
Experience in Immunology Research
With over 20 years of experience in immunology and pharmaceutical research, Tinghua CAO has a significant track record in both academic and industrial research settings. His work at Baylor Institute for Immunology Research included several important immunology research projects. Throughout his career, he has developed and led numerous research initiatives in the field, demonstrating his expertise and dedication to advancing scientific understanding in immunology.
Career at Bristol Myers Squibb
Since joining Bristol Myers Squibb in January 2021, Tinghua CAO has brought his extensive experience in immunology to the company. As a Principal Scientist, he plays a key role in leading research projects and contributing to the development of new therapies. His background in both academic and industrial research positions him as a valuable asset to Bristol Myers Squibb's scientific endeavors.